ASX:BOTPharmaceuticals
Botanix Pharmaceuticals (ASX:BOT): Evaluating Valuation Following Leadership Changes, Product Rollouts, and Conference Updates
Botanix Pharmaceuticals (ASX:BOT) is drawing fresh attention this month as the company prepares for a major conference appearance, has updated investors on recent performance and product rollouts, and introduced a new joint company secretary to its leadership team.
See our latest analysis for Botanix Pharmaceuticals.
After a series of notable updates, including the appointment of a seasoned company secretary and an upcoming presentation at the Canaccord Genuity Drug & Device Conference,...